SCHEMBL28362534

SCHEMBL28362534

CC(C)(C)OC(=O)C(C)(C)c1ccc(Nc2cc(-c3c(F)cccc3F)nnc2C(N)=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 13/20 0.51
▸ JAK1 P23458 9/20 0.51
▸ TYK2 P29597 9/20 0.51
▸ JAK3 P52333 9/20 0.51
▸ DHODH Q02127 1/20 0.36
▸ SYK P43405 5/20 0.36
▸ KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29552328 1.00 JAK2 (0.51) JAK2JAK1TYK2JAK3DHODH
SCHEMBL28359046 0.94 JAK2 (0.60) JAK2JAK1TYK2JAK3SYK
SCHEMBL29552451 0.94 JAK2 (0.60) JAK2JAK1TYK2JAK3SYK
SCHEMBL29552218 0.91 JAK2 (0.43) JAK2JAK1TYK2JAK3DHODH
SCHEMBL29922686 0.90 JAK2 (0.42) JAK2JAK1TYK2JAK3DHODH
SCHEMBL28362586 0.90 JAK2 (0.42) JAK2JAK1TYK2JAK3DHODH
SCHEMBL28359103 0.90 JAK2 (0.54) JAK2JAK1TYK2JAK3DHODH
SCHEMBL29552215 0.90 JAK2 (0.54) JAK2JAK1TYK2JAK3DHODH
SCHEMBL28362644 0.86 JAK2 (0.52) JAK2JAK1TYK2JAK3
SCHEMBL28359254 0.86 JAK2 (0.55) JAK2JAK1TYK2JAK3DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 — — CN disclosed
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
CN-110818641-A Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2020-02-21 — — CN disclosed
Send feedback